Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,283 | 35,903 | 37,431 | 38,487 | 40,156 |
| Other current assets | 537 | 767 | 161 | 405 | 599 |
| TOTAL | $33,820 | $36,670 | $37,592 | $38,892 | $40,755 |
| Non-Current Assets | |||||
| PPE Net | 4 | 7 | 10 | 13 | 17 |
| Other Non-Current Assets | 20 | 29 | 259 | 279 | 311 |
| TOTAL | $24 | $36 | $269 | $292 | $328 |
| Total Assets | $33,844 | $36,706 | $37,861 | $39,184 | $41,083 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 571 | 529 | 362 | 322 | 241 |
| Accrued Expenses | 700 | 1,052 | 275 | 670 | 1,361 |
| TOTAL | $1,271 | $1,581 | $637 | $992 | $1,602 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 204 | 224 | 243 |
| TOTAL | $N/A | $N/A | $204 | $224 | $243 |
| Total Liabilities | $1,271 | $1,581 | $841 | $1,216 | $1,845 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,208 | 1,208 | 1,208 | 1,200 | 1,200 |
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -193,428 | -190,750 | -188,741 | -187,652 | -186,228 |
| TOTAL | $32,573 | $35,125 | $37,020 | $37,968 | $39,238 |
| Total Liabilities And Equity | $33,844 | $36,706 | $37,861 | $39,184 | $41,083 |